Identification of novel PPARα ligands by the structural modification of a PPARγ ligand

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 12, 2006, Pages 3249-3254

  Usui, Shinya ^a   Fujieda, Hiroki ^a   Suzuki, Takayoshi ^a   Yoshida, Naoaki ^a   Nakagawa, Hidehiko ^a   Miyata, Naoki ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Nuclear receptor; Peroxisome proliferator activated receptor; PPAR ligand; PPAR ligand

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PROPIONIC ACID DERIVATIVE; LIGAND;

ARTICLE; CHEMICAL MODIFICATION; DRUG DESIGN; DRUG IDENTIFICATION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ISOMER; STRUCTURE ACTIVITY RELATION; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM;

LIGANDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PPAR ALPHA; PPAR GAMMA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33646187542     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.03.031     Document Type: Article

References (27)

1. Nuclear Receptors Nomenclature Committee. Cell 1999, 97, 161.
2. Willson T.M., Brown P.J., Sternbach D.D., and Henke B.R. J. Med. Chem. 43 (2000) 527
3. Willson T.M., Cobb J.E., Cowan D.J., Wiethe R.W., Correa I.D., Prakash S.R., Beck K.D., Moore L.B., Kliewer S.A., and Lehmann J.M. J. Med. Chem. 39 (1996) 665
4. Kersten S., Desvergne B., and Wahli W. Nature 405 (2000) 421
5. Bogacka I., Xie H., Bray G.A., and Smith S.R. Diabetes Care 27 (2004) 1660
6. Francis G.A., Annicotte J.S., and Auwerx J. Curr. Opin. Pharmacol. 3 (2003) 186
7. Cantello B.C.C., Cawthorone M.A., Cottam G.P., Duff P.T., Haigh D., Hindley R.M., Lister C.A., Smith S.A., and Thurlby P.L. J. Med. Chem. 37 (1994) 3977
8. Momose Y., Meguro K., Ikeda H., Hatanaka C., Oi S., and Sohda T. Chem. Pharm. Bull. 39 (1991) 1440
9. Lohray B.B., Lohray V.B., Bajji A.C., Kalchar S., Poondra R.R., Padakanti S., Chakrabarti R., Vikramadithyan R.K., Misra P., Juluri S., Mamidi N.V., and Rajagopalan R. J. Med. Chem. 44 (2001) 2675
10. Duran-Sandoval D., Thomas A.C., Bailleul B., Fruchart J.C., and Staels B. Med. Sci. 19 (2003) 819
11. Henke B.R. J. Med. Chem. 47 (2004) 4118
12. Forman B.M., Tontonoz P., Chen J., Brun R.P., Spiegelman B.M., and Evans R.M. Cell 83 (1995) 803
13. Kliewer S.A., Lenhard J.M., Willson T.M., Patel I., Morris D.C., and Lehmann J.M. Cell 83 (1995) 813
14. Usui S., Suzuki T., Hattori Y., Etoh K., Fujieda H., Nishizuka M., Imagawa M., Nakagawa H., Kohda K., and Miyata N. Bioorg. Med. Chem. Lett. 15 (2005) 1547
15. Nomura M., Tanase T., Ide T., Tsunoda M., Suzuki M., Uchiki H., Murakami K., and Miyachi H. J. Med. Chem. 46 (2003) 3581
16. Weigand S., Bischoff H., Dittrich-Wengenroth E., Heckroth H., Lang D., Vaupel A., and Woltering M. Bioorg. Med. Chem. Lett. 15 (2005) 4619
17. Kasuga J., Makishima M., Hashimoto Y., and Miyachi H. Bioorg. Med. Chem. Lett. 16 (2006) 554
18. The X-ray structure of PPARα complexed with GW409544 was taken from the Brookhaven Protein Data Bank (PDB code 1K7L). The protein was prepared for docking, using the protein preparation and refinement utility provided by Glide 3.5 software. Water molecules of crystallization were removed from the complexes, and hydrogen atoms were added computationally at appropriate positions. Calculations of docking between the prepared PPARα protein and compound 2 or 10 were performed using Glide 3.5 software.
19. Wagaw S., and Buchwald S.L. J. Org. Chem. 61 (1996) 7240
20. Maryanoff B.E., and Reitz A.B. Chem. Rev. 89 (1989) 863
21. Grieco P.A., and Handy S.T. Tetrahedron Lett. 38 (1997) 2645
22. Kanayama T., Mamiya S., Nishihara T., and Nishikawa J. J. Biochem. 133 (2003) 791
23. Brown P.J., Stuart L.W., Hurley K.P., Lewis M.C., Winegar D.A., Wilson J.G., Wilkison W.O., Ittoop O.R., and Willson T.M. Bioorg. Med. Chem. Lett. 11 (2001) 1225
24. Sznaidman M.L., Haffner C.D., Maloney P.R., Fivush A., Chao E., Goreham D., Sierra M.L., LeGrumelec C., Xu H.E., Montana V.G., Lambert M.H., Willson T.M., Oliver Jr. W.R., and Sternbach D.D. Bioorg. Med. Chem. Lett. 13 (2003) 1517
25. Lowe D.B., Bifulco N., Bullock W.H., Claus T., Coish P., Dai M., Dela Cruz F.E., Dickson D., Fan D., Hoover-Litty H., Li T., Ma X., Mannelly G., Monahan M.K., Muegge I., O'Connor S., Rodriguez M., Shelekhin T., Stolle A., Sweet L., Wang M., Wang Y., Zhang C., Zhang H.J., Zhang M., Zhao K., Zhao Q., Zhu J., Zhu L., and Tsutsumi M. Bioorg. Med. Chem. Lett. 16 (2006) 297
26. Koyama H., Boueres J.K., Miller D.J., Berger J.P., MacNaul K.L., Wang P.R., Ippolito M.C., Wright S.D., Agrawal A.K., Moller D.E., and Sahoo S.P. Bioorg. Med. Chem. Lett. 15 (2005) 3347
27. Koyama H., Miller D.J., Boueres J.K., Desai R.C., Jones A.B., Berger J.P., MacNaul K.L., Kelly L.J., Doebber T.W., Wu M.S., Zhou G., Wang P.R., Ippolito M.C., Chao Y.S., Agrawal A.K., Franklin R., Heck J.V., Wright S.D., Moller D.E., and Sahoo S.P. J. Med. Chem. 47 (2004) 3255